NEW YORK (Reuters) - Ads for Pfizer Inc.'s Celebrex arthritis drug are set to splash across U.S. television screens on Monday after more than a two-year hiatus, with an unusual upfront focus on its ...

Pfizer reported Friday that a study has found an increased risk of heart problems in patients taking its pain medication Celebrex. The increased heart risk was found in one of two long-term cancer ...

JERUSALEM (Legal Newsline) — Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic medications, announced Thursday that its U.S. subsidiary has entered into a settlement with ...

Strides Pharma Global, Singapore, has received approval for celecoxib capsules, 100 mg, 200 mg and 400 mg from the Food and Drug Administration. The product is the generic of Upjohn’s Celebrex. The ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

PHILADELPHIA - New research suggests that top-selling pain reliever Celebrex does not carry the same heart attack risk as Vioxx, a similar drug pulled from the market in September because of safety ...

It’s been a painful 15 months both for people with arthritis and for the companies that make their painkilling drugs. The once high-flying anti-inflammatories known as cox-2 inhibitors nearly crashed ...

April 7, 2005 — -- The Food and Drug Administration asked Pfizer Inc. to pull the painkiller Bextra off the shelves today in a voluntary recall after considering data that the drug poses ...

NEW YORK (Reuters) - Pfizer Inc has won a U.S. court ruling that could limit lawsuits alleging its painkiller Celebrex caused heart attacks and strokes. Judge Charles Breyer of U.S. district court for ...

Pfizer says a study found an increased risk of heart problems with the painkiller Celebrex. The news comes after another painkiller, Vioxx, was withdrawn from the market. Like Vioxx, Celebrex is in a ...